Shujun Xiao

539 total citations
18 papers, 312 citations indexed

About

Shujun Xiao is a scholar working on Molecular Biology, Oncology and Biotechnology. According to data from OpenAlex, Shujun Xiao has authored 18 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Biotechnology. Recurrent topics in Shujun Xiao's work include Cancer-related Molecular Pathways (5 papers), Cancer Research and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Shujun Xiao is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Cancer Research and Treatments (3 papers) and Advanced biosensing and bioanalysis techniques (3 papers). Shujun Xiao collaborates with scholars based in China, Canada and United Kingdom. Shujun Xiao's co-authors include Min Lü, Jiale Wu, Huaxin Song, Yangfei Xing, Ying Liang, Zhengyuan Wang, Ni Yan, Xin Lü, Sai‐Juan Chen and Lili Wu and has published in prestigious journals such as Nature reviews. Cancer, Cancer Cell and Journal of Medicinal Chemistry.

In The Last Decade

Shujun Xiao

17 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shujun Xiao China	8	186	109	60	30	28	18	312
Ji-Hong Ren China	10	254 1.4×	84 0.8×	108 1.8×	5 0.2×	11 0.4×	14	354
Anneliese Gonzalez United States	10	101 0.5×	118 1.1×	65 1.1×	22 0.7×	12 0.4×	23	348
Yolla Haibe Lebanon	8	196 1.1×	155 1.4×	106 1.8×	8 0.3×	15 0.5×	15	404
Upal Kunal Basu Roy United States	8	208 1.1×	93 0.9×	45 0.8×	16 0.5×	9 0.3×	17	339
Quanyi Lu China	11	270 1.5×	69 0.6×	117 1.9×	79 2.6×	8 0.3×	52	425
Tanjing Song China	13	341 1.8×	133 1.2×	62 1.0×	12 0.4×	16 0.6×	19	479
Melissa A. Yao United States	6	132 0.7×	71 0.7×	69 1.1×	8 0.3×	8 0.3×	8	273
Shawn M. Heidel United States	9	185 1.0×	68 0.6×	102 1.7×	23 0.8×	9 0.3×	11	428
Lokman Varışlı Türkiye	11	261 1.4×	94 0.9×	100 1.7×	22 0.7×	10 0.4×	28	410
Klaus-Peter Gilbertz Germany	9	148 0.8×	92 0.8×	59 1.0×	21 0.7×	7 0.3×	14	344

Countries citing papers authored by Shujun Xiao

Since Specialization

Citations

This map shows the geographic impact of Shujun Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujun Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujun Xiao more than expected).

Fields of papers citing papers by Shujun Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujun Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujun Xiao. The network helps show where Shujun Xiao may publish in the future.

Co-authorship network of co-authors of Shujun Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Shujun Xiao. A scholar is included among the top collaborators of Shujun Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujun Xiao. Shujun Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wu, Jiaqi, Huaxin Song, Shujun Xiao, & Min Lü. (2025). Heterogeneity of TP53 mutations necessitates differentiation with p53-rescue therapies. Nature reviews. Cancer. 25(7). 561–563.

Zhang, Shuang, Shuang Zhang, Baohui Wang, et al.. (2025). Pharmacological rescue of mutant p53 triggers spontaneous tumor regression via immune responses. Cell Reports Medicine. 6(3). 101976–101976. 1 indexed citations

Song, Huaxin, et al.. (2024). Drugging p53: Barriers, Criteria, and Prospects. Cancer Discovery. 14(11). 2055–2060. 2 indexed citations

An, Quanlin, Huaxin Song, Shujun Xiao, et al.. (2023). AcGlcAs: A Novel P53-Targeting Arsenical with Potent Cellular Uptake and Cancer Cell Selectivity. Journal of Medicinal Chemistry. 66(24). 16579–16596. 3 indexed citations

Li, Jiabing, Shujun Xiao, Fangfang Shi, et al.. (2023). Arsenic trioxide extends survival of Li–Fraumeni syndrome mimicking mouse. Cell Death and Disease. 14(11). 783–783. 3 indexed citations

Xiao, Shujun, Zhengyuan Wang, Ying Liang, et al.. (2022). A Prognostic Model for Acute Myeloid Leukemia Based on IL-2/STAT5 Pathway-Related Genes. Frontiers in Oncology. 12. 785899–785899. 6 indexed citations

Yan, Ni, Yangfei Xing, Jiale Wu, et al.. (2022). Developmental arsenic exposure impairs cognition, directly targets DNMT3A, and reduces DNA methylation. EMBO Reports. 23(6). e54147–e54147. 15 indexed citations

Xiao, Shujun, et al.. (2021). Effect of high-quality nursing on negative psychological moods and quality of life of elderly patients with hypertension.. PubMed. 13(4). 3710–3716. 5 indexed citations

Li, Xing, Jianhua Ma, Hua Li, et al.. (2021). Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease.. American Journal of Translational Research. 13(4). 2546–2554. 7 indexed citations

10.

Ni, Qingtao, et al.. (2020). <p>Success of <sup>125</sup>I-Seed Treatment in Vulvar Squamous-Cell Carcinoma with Aplastic Anemia: A Case Report</p>. OncoTargets and Therapy. Volume 13. 12561–12566. 1 indexed citations

11.

Chen, Shuo, Jiale Wu, Ying Liang, et al.. (2020). Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site. Cancer Cell. 39(2). 225–239.e8. 177 indexed citations

12.

Gong, Ke, et al.. (2020). Back propagation neural network analysis for the detection of explosives based on tagged neutron. Journal of Radioanalytical and Nuclear Chemistry. 326(1). 329–336. 7 indexed citations

13.

Yu, Yang, Dongke Wang, Qi Zhou, et al.. (2020). Recommendations in clinical practice guidelines on gout: systematic review and consistency analysis.. PubMed. 38(5). 964–972. 7 indexed citations

14.

Ling, Binbing, et al.. (2019). Probing the Antitumor Mechanism of Solanum nigrum L. Aqueous Extract against Human Breast Cancer MCF7 Cells. Bioengineering. 6(4). 112–112. 22 indexed citations

15.

Wang, Peng, Gaohua Han, Shengbin Dai, et al.. (2019). Downregulated lncRNA UCA1 acts as ceRNA to adsorb microRNA-498 to repress proliferation, invasion and epithelial mesenchymal transition of esophageal cancer cells by decreasing ZEB2 expression. Cell Cycle. 18(18). 2359–2376. 22 indexed citations

16.

Xiao, Shujun & Jian Yang. (2018). Preclinical study of the antitumor effect of sphingosine-1-phosphate receptor 1 antibody (S1PR1-antibody) against human breast cancer cells. Investigational New Drugs. 37(1). 57–64. 12 indexed citations

17.

Bai, Qifeng, Lanlan Li, Shanhui Liu, Shujun Xiao, & Yu Guo. (2018). Drug Design Progress of in Silico, in Vitro and in Vivo Researches. 1(1). 16. 5 indexed citations

18.

Chen, Xiaomei, Qi Zhou, Shujun Xiao, et al.. (2017). Efficacy of Purtscher’s Retinopathy Treatments: A Systematic Review. Current Eye Research. 42(6). 908–917. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact